Added to YB: 2025-02-28
Pitch date: 2025-02-26
HIMS [bearish]
Hims & Hers Health, Inc.
+52.95%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$43.21
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
N/A
HIMS short
HIMS short: Switching from Semaglutide to less effective Liraglutide. Margins compressed due to packaging costs. Can't source Ozempic/Wegovy. $240M 2024 rev from GLP-1 at risk. 57% 2025 growth guide relies on weight loss biz despite headwinds. Stock up 230% since GLP-1 announcement, likely to drift lower.
Read full article (1 min)